Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00682669 · ClinicalTrials.gov registry record · Phase 1
Asthma and Mindfulness-Based Stress Reduction (MBSR)
A Phase 1 study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- Phase 1
- Development phase
- 83
- Enrollment target
NCT00682669 is a Phase 1 study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 83 participants.
The verdict
NCT00682669, a Phase 1 study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 83 participants
- Enrollment target
Study Summary
Asthma is one of the four most common chronic disorders in adults, affecting 14 million adults in the United States and costing an estimated 7.9 billion dollars in medical care and 5.3 billion dollars in lost work or school. About 40% of asthmatics report using some form of complementary and alternative medicine approach to help reduce their asthma symptoms, but there is little evidence for their effectiveness. Mindfulness-based stress reduction (MBSR) is a group based program shown to reduce medical symptoms and improve quality of life for patients with many different chronic diseases. The goals of the proposed randomized controlled trial are to collect preliminary data on the effect of MBSR on quality of life, symptoms, and lung function in mild and moderate-severity asthmatics and to refine recruitment and data collection procedures for a future, larger clinical trial.
Interventions
- BEHAVIORAL MBSR
- BEHAVIORAL HLC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2006-09 |
| Est. Completion | 2009-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00682669
The ClinicalTrials.gov registry entry for NCT00682669 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MBSR is the first listed.
NCT00682669 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00682669 about?
NCT00682669 is a clinical study titled "Asthma and Mindfulness-Based Stress Reduction (MBSR)". Asthma is one of the four most common chronic disorders in adults, affecting 14 million adults in the United States and costing an estimated 7.9 billion dollars in medical care and 5.3 billion dollars in lost work or school. About 40% of asthmatics report using some form of complementary and alterna...
What is the current status of trial NCT00682669?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 83 participants. The study started on 2006-09. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00682669?
The interventions under investigation include: MBSR (BEHAVIORAL), HLC (BEHAVIORAL).
Who is sponsoring clinical trial NCT00682669?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.